Carcinoembryonic antigen in metastatic colorectal cancer

Clinical and Investigative Medicine

Volumn 21, Issue 4-5, 1998, Pages 186-191

  Hamm, Caroline M ^a   Cripps, Christine ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; SPARFOSIC ACID;

ADULT; AGED; ARTICLE; CALCULATION; CANADA; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031755540     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. NIH consensus statement: carcinoembryonic antigen: its role as a marker in the management of cancer. BMJ 1981;282:373-5.
2. Allen-Mersch TG, Kemeny N, Neidzwiecke D, Shurgot B, Daly JM. Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer. Gut 1987;28:1625-9.
3. Al-Sarraf M, Baker L, Talley RW, Kithier K, Vaitkevicius VK. The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy. A Southwest Oncology Group Study. Cancer 1919;44:1222-5.
4. Herrera MA, Ming T, Holyoke D, Mittelman A. CEA monitoring of palliative treatment for colorectal carcinoma. Ann Surg 1976;185(1):23-30.
5. Hine HR, Dykes PW. Prospective randomized trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA. Gut 1984;25:682-8.
6. Mayer RJ, Garnick MB, Steele GD, Zamcheck N. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer 1978;42:1428-33.
7. Ravry M, Moertel CG, Schutt AJ, Go VLW. Usefulness of serial serum carcinoembryonic antigen determinations during anticancer therapy of long-term follow up of gastrointestinal carcinoma. Cancer 1974;34:1230-4.
8. Shani A, O'Connell MJ, Moertel CG, Schutt A, Silvers A, Go VLW. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. Ann Intern Med 1978;88:627-30.
9. Simel D, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991;448:763-70.
10. Holland JF, Frei E, Bast RC, Dufe DW, Morton DL, Weichselbaum RR. Cancer medicine. Philadelphia: Lea & Febiger; 1993.
11. DeVita VT, Hellman SH, Rosenberg SA. Cancer principles and practice of oncology. Philadelphia: JB Lippicott; 1993.
12. Staab HJ, Anderer FA, Hornung A, Stumpf E, Fischer R. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br J Cancer 1982;46:773-81.